News

Published on 5 May 2024 on Simply Wall St. via Yahoo Finance

Results: Harmony Biosciences Holdings, Inc. Beat Earnings Expectations And Analysts Now Have New...


Article preview image

Investors in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) had a good week, as its shares rose 7.7% to close at US$31.57 following the release of its first-quarter results. It looks like a credible result overall - although revenues of US$155m were in line with what the analysts predicted, Harmony Biosciences Holdings surprised by delivering a statutory profit of US$0.67 per share, a notable 11% above expectations. Earnings are an important time for investors, as they can track a company's performance, look at what the analysts are forecasting for next year, and see if there's been a change in sentiment towards the company. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year.

View our latest analysis for Harmony Biosciences Holdings

earnings-and-revenue-growthearnings-and-revenue-growth

NASDAQ.HRMY price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Is Harmony Biosciences Holdings, Inc.'s (NASDAQ:HRMY) Recent Stock Performance...

Most readers would already be aware that Harmony Biosciences Holdings' (NASDAQ:HRMY) stock increa...

Simply Wall St. · via Yahoo Finance 25 Jan 2025

Harmony Biosciences Holdings Inc (HRMY) Q3 2024 Earnings Call Highlights: Strong...

Harmony Biosciences Holdings Inc (HRMY) reports robust financial performance with significant...

GuruFocus.com · via Yahoo Finance 29 Oct 2024

Is Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) The Top Stock With Improving...

We recently made a list of Piper Sandler’s Top Technical Stock Picks: 20 Best Stocks. In this pie...

Insider Monkey · via Yahoo Finance 14 Oct 2024

Harmony Biosciences Holdings Inc (HRMY) Q2 2024 Earnings Call Highlights: Strong...

Net Revenue: $172.8 million, representing 29% growth year-over-year.Net Income (Non-GAAP): $60.6 ...

GuruFocus.com · via Yahoo Finance 7 Oct 2024

Results: Harmony Biosciences Holdings, Inc. Beat Earnings Expectations And Analysts Now Have New...

Investors in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) had a good week, as its shares rose...

Simply Wall St. via Yahoo Finance 5 May 2024

Looking for a Growth Stock? 3 Reasons Why Harmony Biosciences (HRMY) is a Solid Choice

Growth stocks are attractive to many investors, as above-average financial growth helps these sto...

Zacks via Yahoo Finance 1 May 2024

Needham raises Harmony Biosciences stock target on growth strategy By Investing.com

Wednesday, Needham, a well-known investment firm, raised its stock price target for Harmony ...

Investing.com 1 May 2024

HRMY or TECH: Which Is the Better Value Stock Right Now?

Investors interested in Medical - Biomedical and Genetics stocks are likely familiar with Harmony...

Zacks via Yahoo Finance 1 May 2024

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q1 2024 Earnings Call Transcript

Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY) Q1 2024 Earnings Call Transcript April 30, 2024 ...

Insider Monkey via Yahoo Finance 1 May 2024

Harmony Biosciences posts 30% revenue growth in Q1 By Investing.com

Harmony Biosciences Holdings , Inc. (NASDAQ: NASDAQ:HRMY) today announced a 30% increase in net...

Investing.com 30 Apr 2024